Literature DB >> 19523109

Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators.

I Mahmood1.   

Abstract

The objective of this study was to evaluate the predictive performance of pharmacokinetic interspecies scaling of coagulation factors and tissue-type plasminogen activators to predict clearance, volume of distribution at steady-state and half-life in humans from animal data. The human pharmacokinetic parameters were predicted using one, two or at least three animal species. The results of the study indicated that the pharmacokinetic parameters of coagulation factors and tissue-type plasminogen activators can be predicted with reasonable accuracy in humans when three or more animal species are available. Two-species scaling can also be performed, but the accuracy of predicted parameters is less than three-species scaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523109     DOI: 10.1111/j.1365-2516.2009.02054.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  3 in total

1.  A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics.

Authors:  Patrick Poulin
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

2.  Allometry of factor VIII and informed scaling of next-generation therapeutic proteins.

Authors:  Matthew P Kosloski; Dipak S Pisal; Donald E Mager; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2013-04-25       Impact factor: 3.534

3.  Pharmacokinetic Time Course Scaling of a Subcutaneously Administered Pegylated Peptide Conjugate for a First-in-Human Investigation.

Authors:  Elliot Offman; Andrea N Edginton
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.